相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of the nucleic acid-sensing Toll-like receptors
Nicholas A. Lind et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Tools to study and target the Siglec-sialic acid axis in cancer
Heinz Laubli et al.
FEBS JOURNAL (2021)
A primer on cytokines
Prashant Chauhan et al.
CYTOKINE (2021)
Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge
Shiteng Duan et al.
JOURNAL OF IMMUNOLOGY (2021)
How the Signaling Crosstalk of B Cell Receptor (BCR) and Co-Receptors Regulates Antibody Class Switch Recombination: A New Perspective of Checkpoints of BCR Signaling
Zhangguo Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Tolerogenic Nanoparticles Impacting B and T Lymphocyte Responses Delay Autoimmune Arthritis in K/BxN Mice
Amrita Srivastava et al.
ACS CHEMICAL BIOLOGY (2021)
Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
Stephanie van de Wall et al.
TRENDS IN IMMUNOLOGY (2020)
Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma
A. N. Frix et al.
BIOCHEMICAL PHARMACOLOGY (2020)
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
Chongxian Pan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
HLAs, TCRs, and KIRs, a Triumvirate of Human Cell-Mediated Immunity
Zakia Djaoud et al.
Annual Review of Biochemistry (2020)
Targeted glycan degradation potentiates the anticancer immune response in vivo
Melissa A. Gray et al.
NATURE CHEMICAL BIOLOGY (2020)
Antibody-Drug Conjugates: The Last Decade
Nicolas Joubert et al.
PHARMACEUTICALS (2020)
Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy
Xueying Tang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos et al.
NATURE REVIEWS IMMUNOLOGY (2020)
T cell interactions with B cells during germinal center formation, a three-step model
Adi Biram et al.
IMMUNOLOGICAL REVIEWS (2019)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
Kevin O. Saunders
FRONTIERS IN IMMUNOLOGY (2019)
The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity
Anne Barenwaldt et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Inhibition of Allergic Reactivity through Targeting FcεRI-Bound IgE with Humanized Low-Affinity Antibodies
Ke Zhang et al.
JOURNAL OF IMMUNOLOGY (2019)
Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis
Kyle J. Bednar et al.
ACS CHEMICAL BIOLOGY (2019)
Targeted Delivery of Antigen to Activated CD169+ Macrophages Induces Bias for Expansion of CD8+ T Cells
Landon J. Edgar et al.
CELL CHEMICAL BIOLOGY (2019)
Nanoparticle-Based Vaccines Against Respiratory Viruses
Soultan Al-Halifa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Kyoji Tsuchikama et al.
PROTEIN & CELL (2018)
Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer
Olivia Joan Adams et al.
GLYCOBIOLOGY (2018)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
Miriam Y. Kim et al.
CELL (2018)
Bifunctional PD-1 x αCD3 x αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia
Monika Herrmann et al.
BLOOD (2018)
Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity
Takeshi Tsubata
FRONTIERS IN IMMUNOLOGY (2018)
Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation
Christian Bull et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2
Kelly A. Orgel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies
Ke Zhang et al.
JOURNAL OF IMMUNOLOGY (2017)
Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model
Kyle J. Bednar et al.
JOURNAL OF IMMUNOLOGY (2017)
CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells
Wenjie Peng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses
F. Zellweger et al.
ALLERGY (2017)
Precision glycocalyx editing as a strategy for cancer immunotherapy
Han Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation
Bruce S. Bochner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Siglecs Induce Tolerance to Cell Surface Antigens by BIM-Dependent Deletion of the Antigen-Reactive B Cells
Matthew S. Macauley et al.
JOURNAL OF IMMUNOLOGY (2014)
The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
Jennifer Mueller et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
Cory D. Rillahan et al.
CHEMICAL SCIENCE (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice
Yu Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Nanomaterials in the application of tumor vaccines: advantages and disadvantages
X. D. Li et al.
ONCOTARGETS AND THERAPY (2013)
Siglec-8 and Siglec-F, the new therapeutic targets in asthma
Sima Sh. Farid et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2012)
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
Takumi Kiwamoto et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Novel identified receptors on mast cells
Helena Migalovich-Sheikhet et al.
FRONTIERS IN IMMUNOLOGY (2012)
Regulation of B cell functions by the sialic acid-bincing receptors Siglec-G and CD22
Julia Jellusova et al.
FRONTIERS IN IMMUNOLOGY (2012)
Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein
A. Eggel et al.
ALLERGY (2011)
CD22 Regulates Adaptive and Innate Immune Responses of B Cells
Norihito Kawasaki et al.
JOURNAL OF INNATE IMMUNITY (2011)
Mast cell-specific Cre/loxP-mediated recombination in vivo
Julia Scholten et al.
TRANSGENIC RESEARCH (2008)
Imaging of germinal center selection events during affinity maturation
Christopher D. C. Allen et al.
SCIENCE (2007)
Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils
Maria-Theresa Krauth et al.
EXPERIMENTAL HEMATOLOGY (2007)
A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
D'Amato Gennaro et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells
H Yokoi et al.
ALLERGY (2006)
Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling
BE Collins et al.
NATURE IMMUNOLOGY (2006)
Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a
Ido Bachelet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
A chimeric human-cat fusion protein blocks cat-induced allergy
DC Zhu et al.
NATURE MEDICINE (2005)
分享论文
